In addition, overexpression of Bcl-2 can protect prostate cancer cells from apoptosis induced by MDA-7/IL-24, indicating that the caspase machinery activated by MDA-7/IL-24 in LNCaP cells might be preferentially inhibited only by Bcl-2 [29]. This evidence concerns the gene BCL2 and prostate cancer.